This bill replaces the current Section 7 of the Environmental Research, Development, and Demonstration Authorization Act of 1978 with new provisions that reallocate responsibility for chemical hazard identification and dose-response assessments away from the Integrated Risk Information System (IRIS) program and into EPA program offices (Office of Water, Office of Air and Radiation, Office of Land and Emergency Management, Office of Chemical Safety and Pollution Prevention, relevant regional offices, and successors). It requires those program offices to perform covered assessments when they determine a need, to apply a set of enumerated scientific standards, and to produce toxicity values that include ranges and documented uncertainties.
The bill also creates a chemical assessment database maintained by EPA’s Office of Research and Development (ORD), establishes a 15-member Hazard Identification and Dose-Response Steering Committee to avoid duplicated effort and vet third-party work, and obligates ORD to deliver biennial certifications to specific congressional committees that covered assessments complied with the new scientific standards. For compliance officers and program managers, the bill changes who sets toxicity values, how evidence must be documented, and how third-party studies may be incorporated into EPA decision making.
At a Glance
What It Does
The bill directs that chronic-exposure hazard identification and dose-response assessments previously in IRIS be carried out by the relevant EPA program office that determines a need. It requires toxicity values to include ranges and uncertainty, stores results in a new ORD-managed chemical assessment database, and applies specified scientific standards for assessments and third-party reviews.
Who It Affects
EPA program offices and regional offices that will perform assessments; the Office of Research and Development, which must maintain the database and certify compliance; parties submitting third‑party assessments (other federal/state agencies, international bodies, industry, or academic groups); and regulated entities that rely on EPA toxicity values for permitting, cleanup, and standards.
Why It Matters
The change decentralizes a centralized IRIS function, potentially speeding program-specific assessments while creating risks of inconsistent toxicity values across programs. By codifying scientific standards and accepting vetted third-party work, the bill alters the evidentiary pathways that can influence regulatory thresholds and compliance obligations.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill rewrites EPA’s Section 7 to make program offices—not the IRIS program—the front line for chronic-exposure hazard identification and dose-response work. If a program office decides an assessment is needed, that office conducts the analysis using the scientific standards spelled out in the new Section 7B.
ORD keeps a central repository: the chemical assessment database. Completed IRIS entries are preserved there, and program offices must submit updates or new toxicity values to that database.
Toxicity values under the bill are not single, opaque numbers. When data support it, program offices must assign one or more toxicity values that include a range of point estimates and explicitly document sources and magnitudes of uncertainty.
Where multiple point estimates exist, offices must consider all datasets and explain how they chose to represent human health risk. The bill also signals methodological flexibility by asking offices to consider non-linear dose-response modeling where scientifically supported.To reduce redundant work, the bill requires EPA to stand up a Hazard Identification and Dose-Response Steering Committee within 30 days.
The steering committee is charged with resolving overlaps when more than one program office plans an assessment and with vetting third-party assessments that meet stated quality criteria (use of the Section 7B standards, independent review, and consistency with weight-of-evidence). The committee is chaired by ORD’s Assistant Administrator and includes representatives from each relevant program office and each EPA region.ORD bears two continuing responsibilities: operate and update the chemical assessment database and, every two years, certify to House Science, House Energy and Commerce, and Senate Environment and Public Works that covered assessments completed in the period meet the bill’s scientific standards.
Those certifications are documentary and do not, on their face, create a separate appeals or enforcement mechanism; they function as congressional oversight of process compliance.
The Five Things You Need to Know
The bill requires the Office of Research and Development to retain all IRIS assessments in a new chemical assessment database and to update that database when a relevant program office completes a covered assessment.
A Hazard Identification and Dose-Response Steering Committee must be established within 30 days, be chaired by ORD’s Assistant Administrator, and include 15 active, full-time EPA employees with at least one member from each relevant program office and each regional office.
Toxicity values must, when supported by available data, include ranges of point estimates and documented sources and magnitudes of uncertainty rather than a single point estimate.
Third-party assessments can supplement EPA work only if they use the Section 7B scientific standards, have undergone independent review for transparency, completeness, and quality, and reflect the weight of the available scientific evidence.
ORD must submit a certification every two years to three congressional committees (House Science; House Energy and Commerce; Senate Environment and Public Works) attesting that covered assessments completed during the period complied with the Section 7B standards.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Coordinate research spending with program office needs
This subsection requires the EPA Administrator to ensure that environmental research and development funding tied to regulatory program activity reflects the research needs and priorities of the Agency’s program offices and the five-year research plan. Practically, it codifies program office input into ORD and other research spending decisions so that R&D aligns with regulatory use-cases rather than being driven solely by centralized research agendas.
Reassign covered assessments and require multi-point toxicity values
These subsections redirect covered chronic-exposure hazard and dose-response assessments away from the IRIS program and toward the relevant program office that determines a need. They require program offices to apply the Section 7B scientific standards and, when data permit, to assign toxicity values that include ranges of point estimates and explicit statements of uncertainty. When several point estimates are possible, offices must consider all datasets and document how they represent human health risk—an instruction that creates a documentation and analytic obligation beyond issuing a single reference number.
ORD chemical assessment database and biennial certification
ORD must maintain a chemical assessment database containing toxicity values assigned under the bill; this database will retain existing IRIS assessments and accept updates from program offices. ORD also must certify every two years to specified congressional committees that covered assessments completed during the reporting period complied with Section 7B standards. The certification is procedural oversight — it creates reporting obligations and centralized recordkeeping but does not specify enforcement mechanisms for noncompliance.
Definitions framing scope
This subsection defines 'covered assessment' narrowly as chronic-exposure hazard identification and dose-response assessments as understood by EPA before enactment, and it identifies the 'relevant program offices' (Water; Air and Radiation; Land and Emergency Management; Chemical Safety and Pollution Prevention) plus successors and others the Administrator deems relevant. Those definitions set the scope of work shifted out of IRIS and determine which offices have standing to conduct covered assessments.
Steering committee to prevent duplication and vet outside work
Section 7A requires establishing a 15-member internal steering committee to coordinate covered assessments, prevent duplicate efforts, and evaluate third-party assessments for potential use. The committee must meet at least annually, and it must determine the most effective single-assessment approach when multiple offices plan assessments of the same chemical. It also prescribes minimum criteria for third-party work: use of Section 7B standards, independent scientific review for transparency/completeness/quality, and conformity with weight-of-evidence principles.
Enumerated scientific standards for assessments and reviews
Section 7B lays out the scientific touchstones EPA must apply: best available science, integration of all lines of evidence, relevance and reasonableness of methods given intended use, public documentation (balanced with legal/ethical data protections), explicit characterization of variability and uncertainty, independent verification or peer review, reproducibility, and consideration of non-linear dose-response modeling where supported. The list is procedural and evaluative; it prescribes criteria but leaves substantial scientific judgment to the conducting program office.
This bill is one of many.
Codify tracks hundreds of bills on Environment across all five countries.
Explore Environment in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- EPA program offices: They gain authority to perform covered hazard and dose-response assessments relevant to their regulatory missions, which can speed program-specific decision making and allow tailoring of methods to regulatory context.
- Third-party researchers and partner agencies: Organizations that generate high-quality assessments (academic groups, state agencies, other federal bodies, industry consortia) can have their work considered and possibly incorporated if it meets the bill’s independent-review and Section 7B standards.
- Office of Research and Development (ORD): ORD becomes the central repository and certifier, increasing its institutional influence over documentation, record keeping, and the gatekeeping of assessment quality.
- Regulated entities seeking predictability within a program: Firms subject to a specific program office’s permitting or cleanup decisions may see assessments aligned more directly with the regulatory endpoints that affect them.
Who Bears the Cost
- EPA program offices: They inherit new workload, technical responsibilities, and documentation obligations for conducting complex chronic‑exposure assessments previously centralized in IRIS—likely requiring staffing, training, and budget increases.
- Office of Research and Development (ORD): ORD must build and maintain the chemical assessment database and perform biennial certifications, adding sustained administrative and technical costs.
- EPA regions and steering committee members: The 15-member steering committee and required annual coordination add recurring meeting and analytic burdens to staff across regions and programs.
- Regulated community and stakeholders: While some may benefit from tailored assessments, inconsistent methodologies across program offices risk increased compliance costs, permit uncertainty, and potentially more litigation as parties contest differing toxicity values.
Key Issues
The Core Tension
The central dilemma is between decentralizing assessment authority to program offices for responsiveness and contextual relevance versus preserving a single, consistent, transparent national approach to chemical hazard and dose-response assessment; the bill provides mechanisms to mitigate inconsistency but leaves significant discretion and few hard constraints on how program offices will interpret and apply the new scientific standards.
The bill shifts the locus of toxicological judgment from a centralized IRIS program to line program offices while keeping ORD as the documentation and certification hub. That creates a subtle but important implementation trade-off: program offices are closer to regulatory decisions and may tailor methods to use-cases, but decentralization risks inconsistent or non‑comparable toxicity values across statutes and programs.
The steering committee is the intended corrective, but its mandatory meeting cadence (at least once per year) and internal composition raise questions about how quickly and effectively it can resolve overlapping assessments or methodological disputes.
Accepting third-party assessments if they meet Section 7B standards opens EPA to outside science, which can accelerate reviews when high-quality external work exists but also creates avenues for industry-funded studies to be elevated if they pass procedural review. The bill requires independent review for third-party assessments, but it does not define the reviewer selection process or conflict-of-interest safeguards.
Finally, ORD’s biennial certification is a procedural accountability tool, not a substantive audit; the certification attests that standards were used, but it does not prescribe a corrective pathway if an assessment fails to meet those standards, nor does it create a public appeals mechanism tied to the certification.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.